Prosecution Insights
Last updated: April 19, 2026

Mylan Pharma UK Limited

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18012110 FORMULATIONS INCLUDING 5-[3-(3-HYDROXYPHENOXY)AZETIDIN-1-YL]-5-METHYL-2,2-DIPHENYLHEXANAMIDE HAGHIGHATIAN, MINA 1616 Final Rejection Dec 21, 2022
17621610 SYSTEM AND METHOD OF MANUFACTURE FOR INHALATION DEVICE KEENA, ELLA LORRAINE 3724 Final Rejection Dec 21, 2021

Managing Mylan Pharma UK Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month